Reproductive Medicine Associates of New York (RMA of New York) is recognized as a global leader in providing the highest-quality, most advanced in vitro fertilization (IVF) technology available today. RMA of New York is at the forefront of groundbreaking research in infertility and reproductive medicine, and is committed to advancing science for the treatment of infertility.
A wide variety of fertility treatments are available for individuals seeking care from an RMA of New York reproductive specialist, and range from basic infertility care to the most progressive techniques in assisted reproductive technology (ART).
RMA of New York has achieved national recognition for clinical excellence and advanced research in the field of reproductive medicine. The RMA New York physicians, nurses, embryologists, and research professionals have published hundreds of scientific journals, clinical abstracts and peer-reviewed articles, and have received awards from Patient Advocacy Organizations, the American Society of Reproductive Medicine, Ivy League Institutions, and several of the top medical schools in the country. They are actively involved in numerous clinical studies and FDA trials, and have partnered with some of the world’s most advanced IVF technology innovators to vastly improve treatment for the millions of individuals currently facing infertility.
To participate in one of our ongoing clinical studies which will improve the means in which treatments are offered, please inquire by emailing Joseph Lee, email@example.com or calling 212-756-5777 ext. 314.
Women’s Genetic Signature:
RMA is working with a biotechnology company, Celmatix, on a study focused on the genetic and phenotypic risk factors underlying female infertility. The study’s goal is to discover genetic sequences and/or mutations within female patients which may be linked to their fertility. The findings from the study are expected to alleviate genetic risk factors for a number of fertility issues at an earlier stage and foster better treatment regimens for future IVF patients. To learn more, click here
Press Release: Reproductive Medicine Associates of New York Unveils Encouraging Data on Aneuploidy Rates in Embryos of Patients Carrying BRCA Mutation at 2016 ASRM Conference View the article here ...READ MORE
Hereditary Breast and Ovarian Cancers: Assessing Your Risk and Steps to Take in Securing Your Future Family Building Options By Matthew A. Lederman MD BRCA1 and BRCA2 mutations account for the majority of families with a hereditary breast and ovarian cancer syndrome. These women are at a higher risk of developing both breast and ovarian cancer, and at a ...READ MORE
Egg Freezing Event: Take Control of Your Fertility Thursday, October 27th 2016 6:30pm-8:30pm ...READ MORE
Egg Freezing Event: Take Control of Your Fertility Thursday, September 29th 2016 6:30pm-8:30pm ...READ MORE
to receive all the latest News, Events & MORE!